MedPage Today on MSN2d
Mixed Results for Therapeutic Candidates for Platinum-Resistant Ovarian CancerPromising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...
The Brighterside of News on MSN2d
Major discovery identifies the cause of ovarian cancerOvarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.
TheHealthSite on MSN2d
Ovarian Cancer Symptoms: Could Your Abdominal Pain and Bloating Be a Sign of Ovarian Cancer? Find Out NowWatch the complete video to know the warning signs that the body may send when you are suffering from ovarian cancer. It ...
An ovarian cancer campaigner, fundraiser and survivor from Norfolk who has taken her story to parliament, is raising awareness of ovarian cancer and the importance of getting checked if something ...
Ovarian cancer is the sixth most common form of cancer in women in the UK - and four symptoms could be signs. One symptom can ...
AROUND 7,500 women are diagnosed with ovarian cancer each year in the UK and 4,100 pass away from it. But symptoms of the ...
Clinical Trials Arena on MSN1d
AbbVie reports final analysis from Phase III trial of Elahere for ovarian cancerAbbVie has reported analysis from a Phase III trial that assessed Elahere against chemotherapy for platinum-resistant ovarian ...
Ovarian cancer is often diagnosed late because its symptoms resemble those of less serious conditions. As a result, only 20% ...
Elizabeth K. Lee, MD, a medical oncologist in the gynecologic oncology program at Dana-Farber, presented results from a phase ...
Ovarian cancer may present a threat to the fallopian tubes and peritoneum. Oncologists Dr. Sai Lakshmi Daayana and Dr. Ajay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback